SHINE Isotope Project Courts Investors at Wisconsin BIO Convention

Matthew Skoufalos | | Radiology Business | Business Intelligence
In support of a second round of start-up capital, representatives from SHINE Medical Technologies took their case to the Wisconsin business community at the state’s International BIO convention. Within the next four years, the company—which is backed heavily by U.S. federal dollars and the Morgridge Institute—claims that it could be producing enough imaging isotopes at its nuclear reactor to meet half the medical needs of the country. “This is a potential $600 million a year market,’’ SHINE CEO Greg Piefer said, according to the website Wisbusiness. Domestic isotope security in the United States has been a matter of concern in recent years, as a handful of reactors provide the world’s supply of molybdenum-99-derived isotopes. Canadian researchers are advocating for a fusion-based solution via a distributed network of particle accelerators.

Matthew Skoufalos

Related Content

Orano Med breaks ground on $265M thorium production site
Image-interpretation market scoreboard: Radiologists 72%, others 28%
Lantheus lands rights to budding radiopharmaceuticals for initial outlay of $35M
17 short-term strategies to address the national radiologist shortage
‘SR’ onboards another independent practice, its 1st in the Natural State
Analysis: Allied radiology professionals generate millions of dollars per year in indirect revenues alone

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.